| Authors: |
Schlaich MP; Dobney Hypertension Centre, Royal Perth Hospital Research Foundation, Medical School, University of Western Australia, Perth, WA 6000, Australia; Department of Cardiology and Department of Nephrology, Royal Perth Hospital, Perth, WA, Australia. Electronic address: markus.schlaich@uwa.edu.au., Bellet M; Global Clinical Development, Idorsia Pharmaceuticals, Allschwil, Switzerland., Weber MA; Downstate College of Medicine, State University of New York, Brooklyn, NY, USA., Bakris GL; Department of Medicine, American Heart Association Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, IL, USA., Wang JG; Department of Hypertension, The Shanghai Institute of Hypertension, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. |
